Literature DB >> 22454930

Correlation between plasma quinidine and cardiac effect.

I R Edwards1, B W Hancock, R Saynor.   

Abstract

1 The relationship between serum quinidine levels and rate-corrected QT (QTc) interval after administration of single identical doses of quinidine was assessed. Quinidine concentrations were determined by a modification of Hamfelt & Malers' (1963) method. The significance and clinical application of our findings is discussed. 2 Individual responses (both in quinidine concentration and QTc prolongation) were variable, though the variation was no greater with QTc prolongation response than with serum quinidine levels. A significant peak in QTc prolongation occurred after quinidine administration and this was not accompanied by a similar peak in quinidine levels. There was some correlation (r = 0.53) between serum quinidine levels and QTc interval but a better correlation was found between rate of rise of quinidine concentration and QTc prolongation (r = 0.87). 3 One individual showed marked QTc prolongation with slow rate of rise of quinidine levels. Red cell quinidine levels were lower in this individual and he may be showing increased myocardial sensitivity to quinidine.

Entities:  

Year:  1974        PMID: 22454930      PMCID: PMC1402542          DOI: 10.1111/j.1365-2125.1974.tb01694.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  2 in total

1.  DETERMINATION OF QUINIDINE CONCENTRATION IN SERUM IN THE CONTROL OF QUINIDINE THERAPY.

Authors:  A HAMFELT; E MALERS
Journal:  Acta Soc Med Ups       Date:  1963

2.  Quinidine elimination in patients with congestive heart failure or poor renal function.

Authors:  K M Kessler; D T Lowenthal; H Warner; T Gibson; W Briggs; M M Reidenberg
Journal:  N Engl J Med       Date:  1974-03-28       Impact factor: 91.245

  2 in total
  4 in total

Review 1.  Therapeutic drug monitoring of antiarrhythmic agents.

Authors:  J E Brown; D G Shand
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

2.  Pharmacokinetics and pharmacodynamics of the antiarrhythmic compound MD750819 in dogs with experimentally induced arrhythmias.

Authors:  J Dow; B Laquais; J Tisne-Versailles; B Pourrias; M S Benedetti
Journal:  J Pharmacokinet Biopharm       Date:  1982-06

3.  Absolute bioavailability of quinidine in two sustained release preparations.

Authors:  J P Amlie; L Storstein; B Olsson; D Fremstad; S Jacobsen
Journal:  Eur J Clin Pharmacol       Date:  1979-08       Impact factor: 2.953

Review 4.  Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy.

Authors:  M J Moore; C Erlichman
Journal:  Clin Pharmacokinet       Date:  1987-10       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.